BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1010 related articles for article (PubMed ID: 26940867)

  • 1. Activation of proto-oncogenes by disruption of chromosome neighborhoods.
    Hnisz D; Weintraub AS; Day DS; Valton AL; Bak RO; Li CH; Goldmann J; Lajoie BR; Fan ZP; Sigova AA; Reddy J; Borges-Rivera D; Lee TI; Jaenisch R; Porteus MH; Dekker J; Young RA
    Science; 2016 Mar; 351(6280):1454-1458. PubMed ID: 26940867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CANCER. The oncogene makes its escape.
    Wala J; Beroukhim R
    Science; 2016 Mar; 351(6280):1398-9. PubMed ID: 27013717
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Alterations of Non-Coding Regions Underlie Human Cancer: Lessons from T-ALL.
    Rivera-Reyes A; Hayer KE; Bassing CH
    Trends Mol Med; 2016 Dec; 22(12):1035-1046. PubMed ID: 28240214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
    Rosson D; Reddy EP
    Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias.
    Bernard O; Guglielmi P; Jonveaux P; Cherif D; Gisselbrecht S; Mauchauffe M; Berger R; Larsen CJ; Mathieu-Mahul D
    Genes Chromosomes Cancer; 1990 Jan; 1(3):194-208. PubMed ID: 1964581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
    Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
    Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible pathogenetic significance of specific chromosome abnormalities and activated proto-oncogenes in malignant diseases of man.
    Pedersen-Bjergaard J; Andersson P; Philip P
    Scand J Haematol; 1986 Feb; 36(2):127-37. PubMed ID: 3518040
    [No Abstract]   [Full Text] [Related]  

  • 9. Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia.
    Watt PM; Kumar R; Kees UR
    Genes Chromosomes Cancer; 2000 Dec; 29(4):371-7. PubMed ID: 11066085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia.
    van der Burg M; Poulsen TS; Hunger SP; Beverloo HB; Smit EM; Vang-Nielsen K; Langerak AW; van Dongen JJ
    Leukemia; 2004 May; 18(5):895-908. PubMed ID: 15042105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic instability and tumor development.
    Nowell PC
    Basic Life Sci; 1991; 57():221-8; discussion 228-31. PubMed ID: 1814285
    [No Abstract]   [Full Text] [Related]  

  • 12. The FEL (AF-4) protein donates transcriptional activation sequences to Hrx-Fel fusion proteins in leukemias containing T(4;11)(Q21;Q23) chromosomal translocations.
    Morrissey JJ; Raney S; Cleary ML
    Leuk Res; 1997 Oct; 21(10):911-7. PubMed ID: 9403001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines.
    Drexler HG; MacLeod RA; Borkhardt A; Janssen JW
    Leukemia; 1995 Mar; 9(3):480-500. PubMed ID: 7885046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tcl-3 proto-oncogene altered by chromosomal translocation in T-cell leukemia codes for a homeobox protein.
    Lu M; Gong ZY; Shen WF; Ho AD
    EMBO J; 1991 Oct; 10(10):2905-10. PubMed ID: 1717256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proto-oncogenes, growth factor genes, receptor genes, differentiation genes and structural rearrangements in human cancer.
    De Braekeleer M
    Anticancer Res; 1988; 8(6):1325-8. PubMed ID: 2851290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1 is required for oncogenic
    Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
    Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal in situ hybridization and the molecular cytogenetics of cancer.
    Emanuel BS
    Surv Synth Pathol Res; 1985; 4(4):269-81. PubMed ID: 3915389
    [No Abstract]   [Full Text] [Related]  

  • 19. Rhom-2 expression does not always correlate with abnormalities on chromosome 11 at band p13 in T-cell acute lymphoblastic leukemia.
    Fitzgerald TJ; Neale GA; Raimondi SC; Goorha RM
    Blood; 1992 Dec; 80(12):3189-97. PubMed ID: 1281693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene amplification in transforming myelodysplasia.
    Papenhausen PR; Griffin S; Tepperberg J
    Exp Mol Pathol; 2005 Oct; 79(2):168-75. PubMed ID: 16026782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.